SDG 3: Ensure healthy lives and promote well-being for all at all ages |
| Targets and Indicators |
| 3.1 By 2030, reduce the global maternal mortality ratio to less than 70 per 100,000 live births |
| 3.1.1 Maternal mortality ratio |
| 3.1.2 Proportion of births attended by skilled health personnel |
| 3.2 By 2030, end preventable deaths of newborns and children under 5 years of age, with all countries aiming to reduce neonatal mortality to at least as low as 12 per 1,000 live births and under-5 mortality to at least as low as 25 per 1,000 live births |
| 3.2.1 Under-five mortality rate |
| 3.2.2 Neonatal mortality rate |
| 3.3 By 2030, end the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases and combat hepatitis, water-borne diseases and other communicable diseases |
| 3.3.1 Number of new HIV infections per 1,000 uninfected population, by sex, age and key populations |
| a. Number of new HIV infections among adults 15–49 years old (per 1000 uninfected population) |
| 3.3.2 Tuberculosis incidence (per 100,000 population) |
| 3.3.3 Malaria incidence (per 1,000 population) |
| 3.3.4 Hepatitis B prevalence (per 100,000 population) |
| 3.3.5 Number of people requiring interventions against neglected tropical diseases |
| a. Leprosy cases |
| b. Kala-azar (Leishmaniasis) cases* |
| c. Lymphatic Filariasis cases |
| d. Dengue cases |
| e. Active Trachoma cases |
| a. % of children under age 5 with Diarrhoea in the last 2 weeks |
| b. Number of laboratory confirmed cases of Influenza (H1N1) |
| 3.4 By 2030, reduce by one third premature mortality from non-communicable diseases through prevention and treatment and promote mental health and well-being |
| 3.4.1 Mortality rate attributed to cardiovascular disease, cancer, diabetes or chronic respiratory disease |
| a. Cardiovascular disease |
| b. Cancer |
| c. Diabetes |
| d. Chronic respiratory disease |
| 3.4.2 Suicide mortality rate (per 100,000 population) |
| 3.5 Strengthen the prevention and treatment of substance abuse, including narcotic drug abuse and harmful use of alcohol |
| 3.5.1 Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders |
| % of hard drug users who ever visited Rehabilitation Centres for comprehensive services |
| 3.5.2 Harmful use of alcohol, defined according to the national context as alcohol per capita consumption (aged 15 years and older) within a calendar year in litres of pure alcohol |
| % of people aged 15 years and older having harmful use of alcohol (defined according to the national context) |
| 3.6 By 2020, halve the number of global deaths and injuries from road traffic accidents |
| 3.6.1 Death rate due to road traffic injuries |
| 3.7 By 2030, ensure universal access to sexual and reproductive health-care services, including for family planning, information and education, and the integration of reproductive health into national strategies and programmes |
| 3.7.1 Proportion of women of reproductive age (aged 15-49 years) who have their need for family planning satisfied with modern methods |
| b. Total Fertility Rate (TFR) (births per women aged 15-49 years) |
| a. Contraceptive prevalence rate (modern methods) (%) |
| 3.7.2 Adolescent birth rate (aged 10-14 years; aged 15-19 years) per 1,000 women in that age group |
| 3.8 Achieve universal health coverage, including financial risk protection, access to quality essential health-care services and access to safe, effective, quality and affordable essential medicines and vaccines for all |
| 3.8.1 Coverage of essential health services (defined as the average coverage of essential services based on tracer interventions that include reproductive, maternal, newborn and child health, infectious diseases, non-communicable diseases and service capacity and access, among the general and the most disadvantaged population) |
| a, % of women having 4 antenatal care visits as per protocol (among live births) |
| b. % of institutional delivery |
| c. % of women attending three PNC as per protocol |
| d. % of infants receiving 3 doses of Hepatitis B vaccine |
| e. % of women aged 30-49 years screened for cervical cancer |
| f. % of people living with HIV receiving Antiretroviral combination therapy |
| g. % of population aged 15 years and above with raised blood pressure who are currently taking medication |
| h. % of population aged 15 years and above with raised blood glucose who are currently taking medication |
| i. % of households within 30 minutes travel time to health facility |
| j. % of poor people enrolled in health insurance |
| 3.8.2 Proportion of population with large household expenditures on health as a share of total household expenditure or income |
| % of out of pocket expenditure in total health expenditure |
| 3.9 By 2030, substantially reduce the number of deaths and illnesses from hazardous chemicals and air, water and soil pollution and contamination |
| 3.9.1 Mortality rate attributed to household and ambient air pollution per 100000 population |
| a. Mortality rate attributed to ambient air pollution |
| b. Mortality rate attributed to household air pollution |
| 3.9.2 Mortality rate attributed to unsafe water, sanitation and hand washing (exposure to unsafe Water, Sanitation and Hygiene for All (WASH) services) per 100000 population |
| 3.9.3 Mortality rate attributed to unintentional poisoning |
| 3a Strengthen the implementation of the World Health Organization Framework Convention on Tobacco Control in all countries, as appropriate |
| 3a.1 Age-standardized prevalence of current tobacco use among persons aged 15 years and older |
| 3b Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all |
| 3b.1 Proportion of the target population covered by all vaccines included in their national programme |
| 3b.2 Total net official development assistance to medical research and basic health sectors (External Funds for Health as % of Total Health Budget) |
| % of health sector budget for research and development |
| 3b.3 Proportion of health facilities that have a core set of relevant essential medicines available and affordable on a sustainable basis |
| % of government health facilities with no stock out of essential drugs |
| 3c Substantially increase health financing and the recruitment, development, training and retention of the health workforce in developing countries, especially in least developed countries and small island developing States |
| 3c.1 Health worker density and distribution (per 1000 population) |
| Total health expenditure as % of GDP |
| 3d Strengthen the capacity of all countries, in particular developing countries, for early warning, risk reduction and management of national and global health risks |
| 3d.1 International Health Regulations (IHR) capacity and health emergency preparedness |
